3-Methyl-2-oxovaleric acid-d₈ sodium

Cat. No.: HY-W017386S: FAQs
Data Sheet Handling Instructions

Molarity Calculator

3-Methyl-2-oxovaleric acid-d₈ (sodium) is the deuterium labeled 3-Methyl-2-oxovaleric acid. 3-Methyl-2-oxovaleric acid is a neurotoxin, an acidogen, and a metabotoxin, and also an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids[1].

For research use only. We do not sell to patients.

3-Methyl-2-oxovaleric acid-d<sub>8</sub> sodium Chemical Structure

3-Methyl-2-oxovaleric acid-d₈ sodium Chemical Structure

CAS No. : 1795037-03-4

Size		Stock
50 mg		Get quote
100 mg		Get quote
250 mg		Get quote
Other size		Get quote

Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other Forms of 3-Methyl-2-oxovaleric acid-d₈ sodium:

3-Methyl-2-oxovaleric acid sodium In-stock

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description	3-Methyl-2-oxovaleric acid-d₈ (sodium) is the deuterium labeled 3-Methyl-2-oxovaleric acid. 3-Methyl-2-oxovaleric acid is a neurotoxin, an acidogen, and a metabotoxin, and also an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids[1].
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. 3-Methyl-2-oxovaleric acid-d₈ sodium Related Antibodies
Molecular Weight	160.17
Formula	C₆HD₈NaO₃
CAS No.	1795037-03-4
SMILES	[2H]C([2H])([2H])C([2H])([2H])C(C([2H])([2H])[2H])C(C(O[Na])=O)=O
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation	Data Sheet (270 KB) Handling Instructions (2659 KB)
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. [Content Brief]